Skip to Content
Discovering the causes of cancer and the means of prevention

Publications Search - Abstract View

Title: Polymorphisms in JAK/STAT signaling pathway genes and risk of non-Hodgkin lymphoma.
Authors: Chen Y,  Lan Q,  Zheng T,  Zhao N,  Holford TR,  Lerro C,  Dai M,  Huang H,  Liang J,  Ma S,  Leaderer B,  Boyle P,  Chanock S,  Rothman N,  Zhang Y
Journal: Leuk Res
Date: 2013 Sep
Branches: HREB, LTG, OD, OEEB
PubMed ID: 23768868
PMC ID: PMC3998836
Abstract: Impaired function of Janus kinase/signal transducer and activator of transcription (JAK/STAT) signaling pathway genes leads to immunodeficiency and various hematopoietic disorders. We evaluated the association between genetic polymorphisms (SNPs) in 12 JAK/STAT pathway genes (JAK3, STAT1, STAT2, STAT3, STAT4, STAT5a, STAT5b, STAT6, SCOS1, SCOS2, SCOS3, and SCOS4) and NHL risk in a population-based case-control study of Connecticut women. We identified three SNPs in STAT3 (rs12949918 and rs6503695) and STAT4 (rs932169) associated with NHL risk after adjustment for multiple comparison. Our results suggest that genetic variation in JAK/STAT pathway genes may play a role in lymphomagenesis and warrants further investigation.